Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,132 | -18,107 | -4,372 | -5,339 | -10,443 |
| Depreciation Amortization | 9,770 | 3,859 | 3,543 | 3,648 | 3,478 |
| Income taxes - deferred | 29 | 116 | 610 | 31 | 454 |
| Accounts receivable | -17,159 | -863 | -2,206 | 2,631 | -2,160 |
| Accounts payable and accrued liabilities | -1,875 | 1,468 | 1,485 | 106 | 779 |
| Other Working Capital | -15,801 | 2,689 | -1,349 | -1,390 | -181 |
| Other Operating Activity | 30,907 | 863 | -935 | -1,880 | 3,921 |
| Operating Cash Flow | $-14,261 | $-9,975 | $-3,224 | $-2,193 | $-4,152 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -260 | -255 | -621 | -620 | -174 |
| Purchase Sale Intangibles | -75,272 | 0 | N/A | N/A | N/A |
| Other Investing Activity | -75,272 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-75,532 | $-255 | $-621 | $-620 | $-174 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 22,500 | 0 | N/A | 4,278 | 42,500 |
| Debt Repayment | -485 | -289 | -221 | -426 | -40,306 |
| Common Stock Issued | 2,404 | 100 | 10,044 | 49 | 902 |
| Common Stock Repurchased | -314 | 0 | N/A | N/A | N/A |
| Other Financing Activity | 72,394 | -113 | 0 | -19 | -2,227 |
| Financing Cash Flow | $96,499 | $-302 | $9,823 | $3,882 | $869 |
| Exchange Rate Effect | 80 | -708 | -676 | 714 | -159 |
| Beginning Cash Position | 5,304 | 16,544 | 11,242 | 9,459 | 13,075 |
| End Cash Position | 12,090 | 5,304 | 16,544 | 11,242 | 9,459 |
| Net Cash Flow | $6,786 | $-11,240 | $5,302 | $1,783 | $-3,616 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,261 | -9,975 | -3,224 | -2,193 | -4,152 |
| Capital Expenditure | -260 | -255 | -621 | -620 | -174 |
| Free Cash Flow | -14,521 | -10,230 | -3,845 | -2,813 | -4,326 |